Charles Schwab Investment Management Inc Alnylam Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 513,962 shares of ALNY stock, worth $127 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
513,962
Previous 487,348 5.46%
Holding current value
$127 Million
Previous $134 Million 9.79%
% of portfolio
0.02%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$232.27 - $300.43 $6.18 Million - $8 Million
26,614 Added 5.46%
513,962 $121 Million
Q3 2024

Nov 12, 2024
BUY
$233.81 - $287.01 $3.92 Million - $4.81 Million
16,756 Added 3.56%
487,348 $134 Million
Q2 2024

Aug 12, 2024
BUY
$143.31 - $247.0 $3.3 Million - $5.69 Million
23,032 Added 5.15%
470,592 $114 Million
Q1 2024

May 08, 2024
BUY
$146.51 - $198.2 $1.36 Million - $1.83 Million
9,256 Added 2.11%
447,560 $66.9 Million
Q4 2023

Feb 06, 2024
BUY
$151.41 - $196.57 $2.93 Million - $3.8 Million
19,324 Added 4.61%
438,304 $83.9 Million
Q3 2023

Nov 08, 2023
BUY
$170.77 - $211.65 $484,303 - $600,239
2,836 Added 0.68%
418,980 $74.2 Million
Q2 2023

Aug 09, 2023
BUY
$185.01 - $212.05 $1.99 Million - $2.29 Million
10,781 Added 2.66%
416,144 $79 Million
Q1 2023

May 11, 2023
BUY
$182.66 - $235.53 $874,393 - $1.13 Million
4,787 Added 1.2%
405,363 $81.2 Million
Q4 2022

Feb 13, 2023
BUY
$185.53 - $241.31 $4.03 Million - $5.24 Million
21,711 Added 5.73%
400,576 $95.2 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $355,770 - $595,776
2,568 Added 0.68%
378,865 $75.8 Million
Q2 2022

Aug 15, 2022
BUY
$120.42 - $169.29 $442,423 - $621,971
3,674 Added 0.99%
376,297 $54.9 Million
Q1 2022

May 13, 2022
BUY
$127.18 - $173.91 $1.23 Million - $1.68 Million
9,662 Added 2.66%
372,623 $60.8 Million
Q4 2021

Feb 11, 2022
BUY
$159.56 - $209.29 $1.62 Million - $2.12 Million
10,146 Added 2.88%
362,961 $61.6 Million
Q3 2021

Nov 16, 2021
BUY
$169.75 - $207.73 $1.61 Million - $1.97 Million
9,484 Added 2.76%
352,815 $66.6 Million
Q2 2021

Aug 16, 2021
BUY
$128.63 - $176.89 $1.17 Million - $1.61 Million
9,118 Added 2.73%
343,331 $58.2 Million
Q1 2021

May 17, 2021
SELL
$126.83 - $175.69 $8.38 Million - $11.6 Million
-66,063 Reduced 16.5%
334,213 $47.2 Million
Q4 2020

Feb 16, 2021
SELL
$122.97 - $147.0 $37,259 - $44,541
-303 Reduced 0.08%
400,276 $52 Million
Q3 2020

Nov 13, 2020
SELL
$121.19 - $165.49 $27.8 Million - $37.9 Million
-229,065 Reduced 36.38%
400,579 $58.3 Million
Q2 2020

Aug 14, 2020
BUY
$104.21 - $156.44 $1.96 Million - $2.94 Million
18,825 Added 3.08%
629,644 $93.3 Million
Q1 2020

May 15, 2020
BUY
$93.12 - $133.99 $935,017 - $1.35 Million
10,041 Added 1.67%
610,819 $66.5 Million
Q4 2019

Feb 07, 2020
BUY
$74.51 - $124.23 $691,303 - $1.15 Million
9,278 Added 1.57%
600,778 $69.2 Million
Q3 2019

Nov 08, 2019
BUY
$70.9 - $87.82 $7.04 Million - $8.72 Million
99,325 Added 20.18%
591,500 $47.6 Million
Q2 2019

Aug 09, 2019
BUY
$65.86 - $92.79 $1.39 Million - $1.96 Million
21,151 Added 4.49%
492,175 $35.7 Million
Q1 2019

May 14, 2019
BUY
$72.76 - $93.45 $8.36 Million - $10.7 Million
114,879 Added 32.26%
471,024 $44 Million
Q4 2018

Feb 14, 2019
BUY
$62.67 - $88.33 $820,914 - $1.16 Million
13,099 Added 3.82%
356,145 $26 Million
Q3 2018

Nov 13, 2018
BUY
$87.52 - $122.67 $3.4 Million - $4.76 Million
38,813 Added 12.76%
343,046 $30 Million
Q2 2018

Aug 08, 2018
BUY
$88.31 - $107.8 $2.37 Million - $2.9 Million
26,881 Added 9.69%
304,233 $30 Million
Q1 2018

May 07, 2018
BUY
$115.92 - $148.54 $1.73 Million - $2.22 Million
14,936 Added 5.69%
277,352 $33 Million
Q4 2017

Jan 17, 2018
BUY
$114.49 - $139.98 $2.05 Million - $2.5 Million
17,866 Added 7.31%
262,416 $33.3 Million
Q3 2017

Nov 13, 2017
BUY
$72.53 - $118.27 $17.7 Million - $28.9 Million
244,550
244,550 $28.7 Million

Others Institutions Holding ALNY

# of Institutions
670
Shares Held
112M
Call Options Held
839K
Put Options Held
771K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.4B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email